Below you will find information from the register publication of inside information. The information has been provided by the organisation.
- Registration date 21 dec 2005 - 08:01
- Statutory name Crucell N.V.
- Title Crucell and DSM Announce PER.C6® Licensing Agreement with ZyStor Therapeutics
- Comments Leiden/Sittard, The Netherlands, December 21, 2005 - Dutch biotechnology company Crucell N.V. (Euronext, NASDAQ: CRXL) and allied contract manufacturer DSM Biologics announced today that they have signed a PER.C6® research license agreement with the private U.S. company ZyStor Therapeutics, Inc.
Date last update: 12 August 2020